OBJECTIVE: The Association in the Presence of Linkage test (APL) is a powerful statistical method that allows for missing parental genotypes in nuclear families. However, in its original form, the statistic does not easily extend to mixed nuclear family structures nor to multiple-marker haplotypes. Furthermore, the robustness of APL in practice has not been examined. Here we present a generalization of the APL model and examination of its robustness under a variety of non-standard scenarios. METHODS: The generalization is made possible by incorporating a bootstrap variance estimator instead of the original robust variance estimator. This allows for use of more than two affected siblings. Haplotype analysis was accomplished by combining estimation of haplotype phase into the EM algorithm. Computer simulation was used to examine robustness of the APL to departures from test assumptions. RESULTS: The extended APL tests both single-marker and multiple-marker haplotypes and shows more power than other association methods. Simulation results showed that the single-marker APL test is robust to the departure from HWE. For the haplotype test, violation of the HWE assumption can inflate type I error. We also evaluated general guidelines for the validity of APL with rare alleles and rare haplotypes. Software for the APL test is available from http://www.chg.duke.edu/research/apl.html. Copyright (c) 2006 S. Karger AG, Basel
OBJECTIVE: The Association in the Presence of Linkage test (APL) is a powerful statistical method that allows for missing parental genotypes in nuclear families. However, in its original form, the statistic does not easily extend to mixed nuclear family structures nor to multiple-marker haplotypes. Furthermore, the robustness of APL in practice has not been examined. Here we present a generalization of the APL model and examination of its robustness under a variety of non-standard scenarios. METHODS: The generalization is made possible by incorporating a bootstrap variance estimator instead of the original robust variance estimator. This allows for use of more than two affected siblings. Haplotype analysis was accomplished by combining estimation of haplotype phase into the EM algorithm. Computer simulation was used to examine robustness of the APL to departures from test assumptions. RESULTS: The extended APL tests both single-marker and multiple-marker haplotypes and shows more power than other association methods. Simulation results showed that the single-marker APL test is robust to the departure from HWE. For the haplotype test, violation of the HWE assumption can inflate type I error. We also evaluated general guidelines for the validity of APL with rare alleles and rare haplotypes. Software for the APL test is available from http://www.chg.duke.edu/research/apl.html. Copyright (c) 2006 S. Karger AG, Basel
Authors: Susan H Blanton; Amber Burt; Elizabeth Garcia; John B Mulliken; Samuel Stal; Jacqueline T Hecht Journal: Cleft Palate Craniofac J Date: 2010-11
Authors: Katelyn S Weymouth; Susan H Blanton; Michael J Bamshad; Anita E Beck; Christine Alvarez; Steve Richards; Christina A Gurnett; Matthew B Dobbs; Douglas Barnes; Laura E Mitchell; Jacqueline T Hecht Journal: Am J Med Genet A Date: 2011-08-10 Impact factor: 2.802
Authors: D Salyakina; D Q Ma; J M Jaworski; I Konidari; P L Whitehead; R Henson; D Martinez; J L Robinson; S Sacharow; H H Wright; R K Abramson; J R Gilbert; M L Cuccaro; M A Pericak-Vance Journal: Autism Res Date: 2010-12 Impact factor: 5.216
Authors: S H Kollins; A D Anastopoulos; A M Lachiewicz; D FitzGerald; E Morrissey-Kane; M E Garrett; S L Keatts; A E Ashley-Koch Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-12-05 Impact factor: 3.568
Authors: Audrey R Ester; Katelyn S Weymouth; Amber Burt; Carol A Wise; Allison Scott; Christina A Gurnett; Matthew B Dobbs; Susan H Blanton; Jacqueline T Hecht Journal: Am J Med Genet A Date: 2009-12 Impact factor: 2.802
Authors: Ravikanth Metlapally; Yi-Ju Li; Khanh-Nhat Tran-Viet; Diana Abbott; Gregory R Czaja; Francois Malecaze; Patrick Calvas; David Mackey; Thomas Rosenberg; Sandrine Paget; Tetyana Zayats; Michael J Owen; Jeremy A Guggenheim; Terri L Young Journal: Invest Ophthalmol Vis Sci Date: 2009-04-22 Impact factor: 4.799